吸收不良症候群的全球市場(2022年～2026年)

全球吸收不良症候群的市場規模在2022年～2026年間，預測將成長到15億5,000萬美元，在預測期間內預計將以7.73％的年複合成長率成長。

市場成長的主要因素有含麩質的食品消費量增加，乳糖不耐症的盛行率上升，政府的配合措施和宣導活動等。

本報告提供全球吸收不良症候群市場相關調查分析，提供市場規模，預測，趨勢，成長促進因素，課題，網羅了約25家供應商的供應商分析等，有系統的資訊。

目錄

第1章 摘要整理

• 市場概要

第2章 市場形勢

• 市場生態系統

第3章 市場規模

• 市場定義
• 市場區隔分析
• 市場規模:2021年
• 市場預測:2021年～2026年的預測

第4章 波特的五力分析

• 五力的摘要
• 買方議價能力
• 供給企業談判力
• 新加入廠商業者的威脅
• 替代品的威脅
• 競爭企業的威脅
• 市場情況

第5章 各疾病類型的市場區隔

• 市場區隔
• 各疾病類型的比較
• 乳糖不耐症:市場規模·預測(2021年～2026年)
• Sprue:市場規模·預測(2021年～2026年)
• 囊狀纖維化症:市場規模·預測(2021年～2026年)
• 各疾病類型的市場機會

第6章 客戶形勢

• 客戶形勢概要

第7章 各地區形勢

• 各地區的市場區隔
• 各地區的比較
• 北美:市場規模·預測(2021年～2026年)
• 歐洲:市場規模·預測(2021年～2026年)
• 亞洲:市場規模·預測(2021年～2026年)
• 其他地區(ROW):市場規模·預測(2021年～2026年)
• 美國:市場規模·預測(2021年～2026年)
• 德國:市場規模·預測(2021年～2026年)
• 中國:市場規模·預測(2021年～2026年)
• 英國:市場規模·預測(2021年～2026年)
• 加拿大:市場規模·預測(2021年～2026年)
• 各地區形勢的市場機會

第8章 促進因素·課題·趨勢

• 推動市場要素
• 市場課題
• 推動因素與課題的影響
• 市場趨勢

第9章 業者情勢

• 概要
• 業者情勢
• 混亂形勢
• 產業的風險

第10章 供應商分析

• 交易廠商
• 供應商的市場定位
• AbbVie Inc.
• Koninklijke DSM NV
• Lannett Co. Inc.
• Merck and Co. Inc.
• Novartis AG
• Organon and Co.
• Perrigo Co. Plc
• Pfizer Inc.
• ProThera Biologics Inc.
• Sanofi

第11章 附錄

Technavio has been monitoring the malabsorption syndrome market and it is poised to grow by $ 1.55 bn during 2022-2026, accelerating at a CAGR of 7.73% during the forecast period. Our report on the malabsorption syndrome market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by higher consumption of gluten-containing food, increasing prevalence of lactose intolerance, and government initiatives and awareness programs.

The malabsorption syndrome market analysis includes the disease type segment and geographic landscape.

Technavio's malabsorption syndrome market is segmented as below:

By Disease Type

• Lactose intolerance
• Sprue
• Cystic fibrosis

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the increased prevalence of cystic fibrosis in Europe, North America, and South America as one of the prime reasons driving the malabsorption syndrome market growth during the next few years. Also, inorganic growth strategies and a robust pipeline of drug manufacturers in the market in focus will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the malabsorption syndrome market covers the following areas:

• Malabsorption syndrome market sizing
• Malabsorption syndrome market forecast
• Malabsorption syndrome market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading malabsorption syndrome market vendors that include AbbVie Inc., Ache Laboratorios Farmaceuticos SA, Aspen Pharmacare Holdings Ltd., Bausch Health Companies Inc., Baxter International Inc., COSMO PHARMACEUTICALS NV, Ferring B.V., Koninklijke DSM NV, Lannett Co. Inc., Merck and Co. Inc., Novartis AG, Organon and Co., Perrigo Co. Plc, ProThera Biologics Inc., Sanofi, Tillotts Pharma AG, Xspire Pharma LLC, and Pfizer Inc. Also, the malabsorption syndrome market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Disease Type
• Exhibit 06: Executive Summary - Chart on Incremental Growth
• Exhibit 07: Executive Summary - Data Table on Incremental Growth
• Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 09: Parent market
• Exhibit 10: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 11: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 12: Market segments
• 3.3 Market size 2021
• 3.4 Market outlook: Forecast for 2021-2026
• Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

• 4.1 Five forces summary
• Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
• 4.2 Bargaining power of buyers
• Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
• 4.3 Bargaining power of suppliers
• Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
• 4.4 Threat of new entrants
• Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
• 4.5 Threat of substitutes
• Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
• 4.6 Threat of rivalry
• Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
• 4.7 Market condition
• Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Disease Type

• 5.1 Market segments
• Exhibit 24: Chart on Disease Type - Market share 2021-2026 (%)
• Exhibit 25: Data Table on Disease Type - Market share 2021-2026 (%)
• 5.2 Comparison by Disease Type
• Exhibit 26: Chart on Comparison by Disease Type
• Exhibit 27: Data Table on Comparison by Disease Type
• 5.3 Lactose intolerance - Market size and forecast 2021-2026
• Exhibit 28: Chart on Lactose intolerance - Market size and forecast 2021-2026 ($ million)
• Exhibit 29: Data Table on Lactose intolerance - Market size and forecast 2021-2026 ($ million)
• Exhibit 30: Chart on Lactose intolerance - Year-over-year growth 2021-2026 (%)
• Exhibit 31: Data Table on Lactose intolerance - Year-over-year growth 2021-2026 (%)
• 5.4 Sprue - Market size and forecast 2021-2026
• Exhibit 32: Chart on Sprue - Market size and forecast 2021-2026 ($ million)
• Exhibit 33: Data Table on Sprue - Market size and forecast 2021-2026 ($ million)
• Exhibit 34: Chart on Sprue - Year-over-year growth 2021-2026 (%)
• Exhibit 35: Data Table on Sprue - Year-over-year growth 2021-2026 (%)
• 5.5 Cystic fibrosis - Market size and forecast 2021-2026
• Exhibit 36: Chart on Cystic fibrosis - Market size and forecast 2021-2026 ($ million)
• Exhibit 37: Data Table on Cystic fibrosis - Market size and forecast 2021-2026 ($ million)
• Exhibit 38: Chart on Cystic fibrosis - Year-over-year growth 2021-2026 (%)
• Exhibit 39: Data Table on Cystic fibrosis - Year-over-year growth 2021-2026 (%)
• 5.6 Market opportunity by Disease Type
• Exhibit 40: Market opportunity by Disease Type ($ million)

6 Customer Landscape

• 6.1 Customer landscape overview
• Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

• 7.1 Geographic segmentation
• Exhibit 42: Chart on Market share By Geographical Landscape 2021-2026 (%)
• Exhibit 43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
• 7.2 Geographic comparison
• Exhibit 44: Chart on Geographic comparison
• Exhibit 45: Data Table on Geographic comparison
• 7.3 North America - Market size and forecast 2021-2026
• Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
• Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
• 7.4 Europe - Market size and forecast 2021-2026
• Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
• Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
• 7.5 Asia - Market size and forecast 2021-2026
• Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
• Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
• 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
• Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• 7.7 US - Market size and forecast 2021-2026
• Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
• Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
• 7.8 Germany - Market size and forecast 2021-2026
• Exhibit 66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibit 67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibit 68: Chart on Germany - Year-over-year growth 2021-2026 (%)
• Exhibit 69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
• 7.9 China - Market size and forecast 2021-2026
• Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ million)
• Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
• Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)
• Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)
• 7.10 UK - Market size and forecast 2021-2026
• Exhibit 74: Chart on UK - Market size and forecast 2021-2026 ($ million)
• Exhibit 75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
• Exhibit 76: Chart on UK - Year-over-year growth 2021-2026 (%)
• Exhibit 77: Data Table on UK - Year-over-year growth 2021-2026 (%)
• 7.11 Canada - Market size and forecast 2021-2026
• Exhibit 78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibit 79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibit 80: Chart on Canada - Year-over-year growth 2021-2026 (%)
• Exhibit 81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
• 7.12 Market opportunity By Geographical Landscape
• Exhibit 82: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends

• 8.1 Market drivers
• 8.2 Market challenges
• 8.3 Impact of drivers and challenges
• Exhibit 83: Impact of drivers and challenges in 2021 and 2026
• 8.4 Market trends

9 Vendor Landscape

• 9.1 Overview
• 9.2 Vendor landscape
• Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
• 9.3 Landscape disruption
• Exhibit 85: Overview on factors of disruption
• 9.4 Industry risks
• Exhibit 86: Impact of key risks on business

10 Vendor Analysis

• 10.1 Vendors covered
• Exhibit 87: Vendors covered
• 10.2 Market positioning of vendors
• Exhibit 88: Matrix on vendor position and classification
• 10.3 AbbVie Inc.
• Exhibit 89: AbbVie Inc. - Overview
• Exhibit 90: AbbVie Inc. - Product / Service
• Exhibit 91: AbbVie Inc. - Key offerings
• 10.4 Koninklijke DSM NV
• Exhibit 92: Koninklijke DSM NV - Overview
• Exhibit 93: Koninklijke DSM NV - Business segments
• Exhibit 94: Koninklijke DSM NV - Key news
• Exhibit 95: Koninklijke DSM NV - Key offerings
• Exhibit 96: Koninklijke DSM NV - Segment focus
• 10.5 Lannett Co. Inc.
• Exhibit 97: Lannett Co. Inc. - Overview
• Exhibit 98: Lannett Co. Inc. - Product / Service
• Exhibit 99: Lannett Co. Inc. - Key news
• Exhibit 100: Lannett Co. Inc. - Key offerings
• 10.6 Merck and Co. Inc.
• Exhibit 101: Merck and Co. Inc. - Overview
• Exhibit 102: Merck and Co. Inc. - Business segments
• Exhibit 103: Merck and Co. Inc. - Key news
• Exhibit 104: Merck and Co. Inc. - Key offerings
• Exhibit 105: Merck and Co. Inc. - Segment focus
• 10.7 Novartis AG
• Exhibit 106: Novartis AG - Overview
• Exhibit 107: Novartis AG - Business segments
• Exhibit 108: Novartis AG - Key offerings
• Exhibit 109: Novartis AG - Segment focus
• 10.8 Organon and Co.
• Exhibit 110: Organon and Co. - Overview
• Exhibit 111: Organon and Co. - Product / Service
• Exhibit 112: Organon and Co. - Key offerings
• 10.9 Perrigo Co. Plc
• Exhibit 113: Perrigo Co. Plc - Overview
• Exhibit 114: Perrigo Co. Plc - Business segments
• Exhibit 115: Perrigo Co. Plc - Key offerings
• Exhibit 116: Perrigo Co. Plc - Segment focus
• 10.10 Pfizer Inc.
• Exhibit 117: Pfizer Inc. - Overview
• Exhibit 118: Pfizer Inc. - Product / Service
• Exhibit 119: Pfizer Inc. - Key news
• Exhibit 120: Pfizer Inc. - Key offerings
• 10.11 ProThera Biologics Inc.
• Exhibit 121: ProThera Biologics Inc. - Overview
• Exhibit 122: ProThera Biologics Inc. - Product / Service
• Exhibit 123: ProThera Biologics Inc. - Key offerings
• 10.12 Sanofi
• Exhibit 124: Sanofi - Overview
• Exhibit 125: Sanofi - Business segments
• Exhibit 126: Sanofi - Key news
• Exhibit 127: Sanofi - Key offerings
• Exhibit 128: Sanofi - Segment focus

11 Appendix

• 11.1 Scope of the report
• 11.2 Inclusions and exclusions checklist
• Exhibit 129: Inclusions checklist
• Exhibit 130: Exclusions checklist
• 11.3 Currency conversion rates for US$
• Exhibit 131: Currency conversion rates for US$
• 11.4 Research methodology
• Exhibit 132: Research methodology
• Exhibit 133: Validation techniques employed for market sizing
• Exhibit 134: Information sources
• 11.5 List of abbreviations
• Exhibit 135: List of abbreviations

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by Disease Type
• Exhibits6: Executive Summary - Chart on Incremental Growth
• Exhibits7: Executive Summary - Data Table on Incremental Growth
• Exhibits8: Executive Summary - Chart on Vendor Market Positioning
• Exhibits9: Parent market
• Exhibits10: Market Characteristics
• Exhibits11: Offerings of vendors included in the market definition
• Exhibits12: Market segments
• Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
• Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
• Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibits17: Five forces analysis - Comparison between 2021 and 2026
• Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
• Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
• Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
• Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
• Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
• Exhibits23: Chart on Market condition - Five forces 2021 and 2026
• Exhibits24: Chart on Disease Type - Market share 2021-2026 (%)
• Exhibits25: Data Table on Disease Type - Market share 2021-2026 (%)
• Exhibits26: Chart on Comparison by Disease Type
• Exhibits27: Data Table on Comparison by Disease Type
• Exhibits28: Chart on Lactose intolerance - Market size and forecast 2021-2026 ($ million)
• Exhibits29: Data Table on Lactose intolerance - Market size and forecast 2021-2026 ($ million)
• Exhibits30: Chart on Lactose intolerance - Year-over-year growth 2021-2026 (%)
• Exhibits31: Data Table on Lactose intolerance - Year-over-year growth 2021-2026 (%)
• Exhibits32: Chart on Sprue - Market size and forecast 2021-2026 ($ million)
• Exhibits33: Data Table on Sprue - Market size and forecast 2021-2026 ($ million)
• Exhibits34: Chart on Sprue - Year-over-year growth 2021-2026 (%)
• Exhibits35: Data Table on Sprue - Year-over-year growth 2021-2026 (%)
• Exhibits36: Chart on Cystic fibrosis - Market size and forecast 2021-2026 ($ million)
• Exhibits37: Data Table on Cystic fibrosis - Market size and forecast 2021-2026 ($ million)
• Exhibits38: Chart on Cystic fibrosis - Year-over-year growth 2021-2026 (%)
• Exhibits39: Data Table on Cystic fibrosis - Year-over-year growth 2021-2026 (%)
• Exhibits40: Market opportunity by Disease Type ($ million)
• Exhibits41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits42: Chart on Market share By Geographical Landscape 2021-2026 (%)
• Exhibits43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
• Exhibits44: Chart on Geographic comparison
• Exhibits45: Data Table on Geographic comparison
• Exhibits46: Chart on North America - Market size and forecast 2021-2026 ($ million)
• Exhibits47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
• Exhibits48: Chart on North America - Year-over-year growth 2021-2026 (%)
• Exhibits49: Data Table on North America - Year-over-year growth 2021-2026 (%)
• Exhibits50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibits51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibits52: Chart on Europe - Year-over-year growth 2021-2026 (%)
• Exhibits53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
• Exhibits54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibits55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibits56: Chart on Asia - Year-over-year growth 2021-2026 (%)
• Exhibits57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
• Exhibits58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibits59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibits60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibits61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibits62: Chart on US - Market size and forecast 2021-2026 ($ million)
• Exhibits63: Data Table on US - Market size and forecast 2021-2026 ($ million)
• Exhibits64: Chart on US - Year-over-year growth 2021-2026 (%)
• Exhibits65: Data Table on US - Year-over-year growth 2021-2026 (%)
• Exhibits66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibits67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibits68: Chart on Germany - Year-over-year growth 2021-2026 (%)
• Exhibits69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
• Exhibits70: Chart on China - Market size and forecast 2021-2026 ($ million)
• Exhibits71: Data Table on China - Market size and forecast 2021-2026 ($ million)
• Exhibits72: Chart on China - Year-over-year growth 2021-2026 (%)
• Exhibits73: Data Table on China - Year-over-year growth 2021-2026 (%)
• Exhibits74: Chart on UK - Market size and forecast 2021-2026 ($ million)
• Exhibits75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
• Exhibits76: Chart on UK - Year-over-year growth 2021-2026 (%)
• Exhibits77: Data Table on UK - Year-over-year growth 2021-2026 (%)
• Exhibits78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibits79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibits80: Chart on Canada - Year-over-year growth 2021-2026 (%)
• Exhibits81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
• Exhibits82: Market opportunity By Geographical Landscape ($ million)
• Exhibits83: Impact of drivers and challenges in 2021 and 2026
• Exhibits84: Overview on Criticality of inputs and Factors of differentiation
• Exhibits85: Overview on factors of disruption
• Exhibits86: Impact of key risks on business
• Exhibits87: Vendors covered
• Exhibits88: Matrix on vendor position and classification
• Exhibits89: AbbVie Inc. - Overview
• Exhibits90: AbbVie Inc. - Product / Service
• Exhibits91: AbbVie Inc. - Key offerings
• Exhibits92: Koninklijke DSM NV - Overview
• Exhibits93: Koninklijke DSM NV - Business segments
• Exhibits94: Koninklijke DSM NV - Key news
• Exhibits95: Koninklijke DSM NV - Key offerings
• Exhibits96: Koninklijke DSM NV - Segment focus
• Exhibits97: Lannett Co. Inc. - Overview
• Exhibits98: Lannett Co. Inc. - Product / Service
• Exhibits99: Lannett Co. Inc. - Key news
• Exhibits100: Lannett Co. Inc. - Key offerings
• Exhibits101: Merck and Co. Inc. - Overview
• Exhibits102: Merck and Co. Inc. - Business segments
• Exhibits103: Merck and Co. Inc. - Key news
• Exhibits104: Merck and Co. Inc. - Key offerings
• Exhibits105: Merck and Co. Inc. - Segment focus
• Exhibits106: Novartis AG - Overview
• Exhibits107: Novartis AG - Business segments
• Exhibits108: Novartis AG - Key offerings
• Exhibits109: Novartis AG - Segment focus
• Exhibits110: Organon and Co. - Overview
• Exhibits111: Organon and Co. - Product / Service
• Exhibits112: Organon and Co. - Key offerings
• Exhibits113: Perrigo Co. Plc - Overview
• Exhibits114: Perrigo Co. Plc - Business segments
• Exhibits115: Perrigo Co. Plc - Key offerings
• Exhibits116: Perrigo Co. Plc - Segment focus
• Exhibits117: Pfizer Inc. - Overview
• Exhibits118: Pfizer Inc. - Product / Service
• Exhibits119: Pfizer Inc. - Key news
• Exhibits120: Pfizer Inc. - Key offerings
• Exhibits121: ProThera Biologics Inc. - Overview
• Exhibits122: ProThera Biologics Inc. - Product / Service
• Exhibits123: ProThera Biologics Inc. - Key offerings
• Exhibits124: Sanofi - Overview
• Exhibits125: Sanofi - Business segments
• Exhibits126: Sanofi - Key news
• Exhibits127: Sanofi - Key offerings
• Exhibits128: Sanofi - Segment focus
• Exhibits129: Inclusions checklist
• Exhibits130: Exclusions checklist
• Exhibits131: Currency conversion rates for US$
• Exhibits132: Research methodology
• Exhibits133: Validation techniques employed for market sizing
• Exhibits134: Information sources
• Exhibits135: List of abbreviations